Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M405Revenue $M0.5Net Margin (%)--Altman Z-Score24.8
Enterprise Value $M337EPS $-0.2Operating Margin %--Piotroski F-Score4
P/E(ttm)--Beneish M-Score-3.6Pre-tax Margin (%)--Higher ROA y-yY
Price/Book6.010-y EBITDA Growth Rate %-3.9Quick Ratio13.0Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %-10.9Current Ratio13.0Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-36.6Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-43.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M82.0ROIC % (ttm)-2,123.9Gross Margin Increase y-yN

Gurus Latest Trades with CPRX

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

CPRX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CPRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MUTH DAVID DEVP, Chief Commercial Officer 2015-05-01Buy1,700$3.254.38 view
O'Keeffe Charles BDirector 2015-04-30Buy10,000$3.2950.15 view
DENKHAUS DONALD ADirector 2015-04-30Buy5,000$3.2552 view
MUTH DAVID DEVP, Chief Commercial Officer 2015-04-28Buy2,000$3.5539.15 view
MCENANY PATRICK JPresident and CEO 2015-04-27Buy5,000$3.7930.34 view
DENKHAUS DONALD ADirector 2015-04-27Buy15,000$3.7133.15 view
O'Keeffe Charles BDirector 2015-04-24Buy5,000$3.830 view
DENKHAUS DONALD ADirector 2015-03-27Buy5,000$4.1718.47 view
MUTH DAVID DEVP, Chief Commercial Officer 2015-01-20Buy21,000$2.9666.89 view
O'Keeffe Charles BDirector 2015-01-13Buy10,000$364.67 view

Quarterly/Annual Reports about CPRX:

News about CPRX:

Articles On GuruFocus.com
Piper Jaffray Remains Bullish on Catalyst Pharmaceuticals Following the Close of its Recent Public O Feb 17 2015 
Weekly CEO Buys Highlight: BH, CLMS, OPK, GPC, CPRX Jan 18 2015 
Weekly CEO Buys Highlight: BH, CLMS, OPK, CPRX, BRT Jan 12 2015 
Largest Insider Buys of the Week Oct 25 2013 
Weekly CFO Buys Highlight: CPRX, APPY, MEI, MNKD Jul 09 2012 
Weekly CFO Buys Highlight: EMC, DVOX, NANX, CPRX, CCRN Jun 04 2012 
Catalyst Pharmaceutical Partners Inc. Reports Operating Results (10-Q) Nov 15 2010 
Catalyst Pharmaceutical Partners Inc. Reports Operating Results (10-Q) Aug 12 2010 
Catalyst Pharmaceutical Partners Inc. (CPRX) CEO Patrick J Mcenany buys 9,359 Shares Jun 16 2010 
Catalyst Pharmaceutical Partners Inc. Reports Operating Results (10-Q) May 17 2010 

More From Other Websites
CATALYST PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 22 2015
Catalyst Pharmaceuticals Initiates Rolling NDA Submission for Firdapse for the Treatment of... Jul 22 2015
Catalyst Pharmaceuticals Initiates Rolling NDA Submission for Firdapse for the Treatment of... Jul 22 2015
CATALYST PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 30 2015
Catalyst Pharmaceuticals Appoints Dr. Gary Ingenito as Chief Medical Officer Jun 30 2015
Catalyst Pharmaceuticals Appoints Dr. Gary Ingenito as Chief Medical Officer Jun 30 2015
Catalyst Pharmaceuticals Joins Russell 2000, 3000 and Global Indexes Jun 29 2015
Catalyst Pharmaceuticals Joins Russell 2000, 3000 and Global Indexes Jun 29 2015
Catalyst Pharmaceuticals Reports Tourette's Disorder Data - Analyst Blog Jun 25 2015
Is Catalyst Pharmaceutical Partners, Inc. (CPRX) a “Buy” after Its Promising Results In... Jun 24 2015
Catalyst Pharmaceuticals Announces Encouraging Top-Line Results in Proof-of-Concept Trial of... Jun 24 2015
CATALYST PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 24 2015
Catalyst Pharmaceuticals Announces Encouraging Top-Line Results in Proof-of-Concept Trial of... Jun 24 2015
4 Breakout Biotech Stocks Under $10 to Watch Jun 18 2015
Five Biotech Stocks for the Next Six Months Jun 17 2015
CATALYST PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits May 28 2015
Catalyst Pharmaceuticals Names Richard J. Daly Interim Chief Commercial Officer May 28 2015
Catalyst Pharmaceuticals Names Richard J. Daly Interim Chief Commercial Officer May 28 2015
CATALYST PHARMACEUTICALS, INC. Financials May 27 2015
Catalyst Pharmaceuticals to Present at the Jefferies 2015 Healthcare Conference May 27 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK